CITALO-50

CITALO-50 is a pharmaceutical tablet formulation containing Cilostazol 50 mg. The product is presented as an oral tablet and forms part of Suprimeda's pharmaceutical portfolio for professional healthcare and institutional requirements. Cilostazol is identified in the product documentation as an antiplatelet agent with vasodilator properties.

Each CITALO-50 tablet contains Cilostazol 50 mg, providing a clearly defined strength for pharmaceutical identification, prescription and procurement purposes. The formulation belongs to the cardiovascular and vascular medicine segment and can be catalogued using relevant pharmaceutical terms including Cilostazol 50 mg tablets, Cilostazol tablets, antiplatelet tablets and vascular medicine formulations.

For hospitals, doctors, healthcare institutions and pharmaceutical procurement teams, CITALO-50 can be identified by its active pharmaceutical ingredient, strength and tablet dosage form. The product image specifies a 20 × 10 tablet packaging configuration, supplied in a blister-pack format.